Session 9A: Leading the future of precision medicine: Translating cancer and vaccine breakthroughs
Tracks
Track 1
| Thursday, October 23, 2025 |
| 3:40 PM - 4:25 PM |
| Pioneer Room |
Overview
Sponsored by: RMIT
Details
Precision medicine is revolutionising how we detect, treat, and prevent disease — but real-world impact demands deep collaboration across science, industry, and policy. This panel convenes leading experts from academia, biotech, pharma, and government to explore how breakthroughs in cancer and vaccine research are being translated into clinical outcomes. With a spotlight on ovarian and age-related cancers, the discussion will be anchored by RMIT’s ATRACT Centre and its leadership in immunotherapy and vaccine innovation. Speakers will explore advances in biomarker-driven drug development, adaptive trial design, scalable diagnostics, and regulatory reform. Case studies from across Australia will showcase how patient-centric, cross-sector models are accelerating the journey from lab to clinic — and shaping the future of personalised healthcare.
Sponsored by:
Speaker
Dist. Prof. Calum Drummond
Deputy Vice-Chancellor (DPVC) Research and Innovation
RMIT University
Panellist
Prof. Katie Flanagan
Senior Staff Specialist at Westmead Hospital in Sydney, recent ex-President of ASID
Westmead Hospital
Panellist
Distinguished Professor Magdalena Plebanski
Director
Accelerator for Translational Research in Clinical Trials (ATRACT) Centre
Chair
